Stratistics MRC에 따르면 세계의 치과용 봉합사 시장은 2025년 2억 3,870만 달러를 차지하고, 2032년에는 4억 1,440만 달러에 이를 것으로 예측되며 측정 기간 동안 CAGR은 8.2%로 예상됩니다.
세계보건기구(WHO)의 세계 구강보건상황보고서(2022년)에 따르면 약 35억 명이 구강질환에 시달리고 있습니다.
치과 수술 증가
세계의 치과 수술 건수 증가는 치과용 봉합사 시장의 주요 촉진요인입니다. 또한, 치과 투어 증가와 구강 건강에 대한 의식 증가가 치과 치료 증가로 이어져 수술 후 상처 폐쇄 및 치유를 적절히 수행하기 위한 치과용 봉합사 수요를 밀어 올리고 있습니다.
고급 봉합사의 높은 비용
개량형 치과용 봉합사, 특히 합성 소재나 신소재로 만들어진 봉합사는 비용이 높기 때문에 시장의 확대가 대폭으로 제한되고 있습니다. 건강 관리 예산 및 상환 규칙이 제한된 지역, 특히 신흥 국가에서는 비용이 높아지기 쉽고 보급을 제한하기 때문에 기존의 저렴한 솔루션이 더욱 매력적이 되어 시장 확대를 방해하고 있습니다.
봉합사의 진보
합성 봉합사, 흡수성 봉합사, 생체 적합성 봉합사의 탄생은 조직의 반응을 억제하고, 치유를 가속시키며, 발사의 필요성을 줄임으로써 수술 성적의 향상으로 이어졌습니다. 이러한 기술적 개량은 치과 의료 종사자의 요구의 변화에 대응할 뿐만 아니라, 특히 저침습으로 효과적인 치과 치료에 대한 수요가 높아지는 가운데, 시장 성장의 새로운 기회도 만들어내고 있습니다.
수술 부위 감염(SSI) 위험
수술 부위 감염(SSI)의 위험은 치과용 봉합사 사업에 여전히 큰 위협입니다. 이러한 우려는 의사가 특정 봉합사를 사용하지 않도록 하거나 다른 상처 폐쇄 방법을 사용하도록 촉구함으로써 시장 성장을 제한할 수 있습니다.
COVID-19의 유행은 치과용 봉합사 업계에 큰 악영향을 미치고, 그 때문에 치과의원의 폐쇄, 사회적 거리두기, 선택적 치과 치료의 캔슬이 퍼졌습니다. 그 결과 치과용 봉합사 수요가 줄어들어 공급망과 시장수익 모두에 타격을 주었습니다.
예측 기간 동안 비 흡수성 봉합사 부문이 최대가 될 것으로 예상
예측 기간 동안 비 흡수성 봉합사 부문이 가장 큰 시장 점유율을 차지할 전망입니다. 폴리프로필렌으로 구성된 이 봉합사는 어려운 구강 수술과 장시간 상처 지지를 필요로 하는 치료에 이상적입니다.
예측 기간 동안 합성 소재 부문의 CAGR이 가장 높을 것으로 예측됩니다.
예측기간 중 합성소재 부문이 가장 높은 성장률을 보일 것으로 예측되고 있습니다. 이 특성은 보다 빨리 치유를 촉진하고 수술 후 문제를 예방합니다.
예측 기간 동안 북미가 가장 큰 시장 점유율을 차지할 것으로 예측됩니다. 만연, 광범위한 치과 보험 적용, 주요 시장 진출기업의 존재로 주도적 지위를 차지하고 있습니다. 또한 이 지역은 최신 치과 기술의 보급과 유리한 상환 규제의 혜택을 받아 세계 시장에서의 리더십을 강화하고 있습니다.
예측 기간 동안 아시아태평양이 가장 높은 CAGR을 나타낼 것으로 예측됩니다. 헬스케어 인프라를 개선하고 구강의 건강을 촉진하기 위한 정부의 대처와 뛰어난 치과 치료를 원하는 중류계급의 인구 증가가 시장의 성장을 뒷받침하고 있습니다.
According to Stratistics MRC, the Global Dental Sutures Market is accounted for $238.7 million in 2025 and is expected to reach $414.4 million by 2032 growing at a CAGR of 8.2% during the forecast period. Dental sutures are sterile surgical threads utilized by dentists or oral surgeons to repair wounds or surgical incisions in the oral cavity following treatments such as tooth extractions, gum surgery, or implants. They facilitate healing by securing tissue and reducing hemorrhage. Dental sutures may be classified as absorbable, which dissolve over time, or non-absorbable, necessitating removal. They are available in diverse materials and dimensions, according to the particular requirements of oral surgery.
According to the World Health Organization's Global Oral Health Status Report (2022), approximately 3.5 billion people worldwide suffer from oral diseases.
Increasing number of dental surgeries
The increasing number of dental procedures worldwide is a major driver of the dental sutures market. This expansion is driven by the rising prevalence of dental problems such as periodontal disease and dental caries, an increase in cosmetic dentistry operations, and an aging population that requires more dental care. Furthermore, the growth of dental tourism and increased awareness of oral health have resulted in a higher volume of dental treatments, boosting the demand for dental sutures to enable proper wound closure and healing following surgery.
High cost of advanced sutures
The high cost of improved dental sutures, particularly those made from synthetic or novel materials, significantly limits market expansion. While these sutures provide greater biocompatibility and predictability of absorption, they are costly due to complex manufacturing techniques and raw material costs. In areas with limited healthcare budgets or reimbursement rules, particularly in developing nations, higher costs limit accessibility and uptake, making traditional, less expensive solutions more appealing and impeding total market expansion.
Advancements in suture materials
The creation of synthetic, absorbable, and biocompatible sutures has led to better surgical outcomes by reducing how much the tissue reacts, helping it heal faster, and making it less necessary to remove the sutures. Furthermore, improvements like antimicrobial coatings and knotless designs lower infection risk while improving patient comfort. These technological improvements not only suit the changing needs of dental professionals, but they also create new opportunities for market growth, particularly as demand for minimally invasive and effective dental procedures increases.
Risk of surgical site infections (SSIs)
The risk of surgical site infections (SSIs) remains a significant threat to the dental suture business. Sutures can become a place where bacteria grow and form a layer, increasing the chance of infections after surgery and other problems. Such concerns may discourage doctors from utilizing specific suture types or encourage the use of alternate wound closure procedures, thereby limiting market growth.
The Covid-19 epidemic had a significant detrimental influence on the dental sutures industry, owing to widespread lockdowns, social distancing measures, and the cancellation of elective dental treatments. As a result, patient visits to dental clinics decreased significantly, as did the number of dental procedures conducted. As a result, demand for dental sutures declined, hurting both supply chains and market revenues. However, once limitations were lifted and dental practices restarted, the market eventually recovered, returning to its pre-pandemic growth rates.
The non-absorbable sutures segment is expected to be the largest during the forecast period
The non-absorbable sutures segment is expected to account for the largest market share during the forecast period. Non-absorbable sutures are preferred in dental surgeries that require long-term tissue support because of their endurance, high tensile strength, and resistance to degradation. These sutures, which are generally comprised of silk, nylon, or polypropylene, are ideal for difficult oral operations and procedures that require extended wound support. Their continuous demand stems from their capacity to preserve wound closure while limiting the possibility of dehiscence, making them vital in dental treatment.
The synthetic material segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the synthetic material segment is predicted to witness the highest growth rate. Synthetic sutures, made from materials like polyglycolic acid, polyglactin, and polydioxanone, are gaining popularity because they work well with the body, dissolve at a steady rate, and cause less irritation to tissues. These qualities promote speedier healing and prevent post-operative problems. Furthermore, current technological improvements in synthetic suture materials, such as antimicrobial coatings and increased flexibility, are improving their effectiveness and propelling their widespread use in various dental procedures.
During the forecast period, the North America region is expected to hold the largest market share. This supremacy is due to improved healthcare infrastructure, great awareness of dental care, and a significant number of dental procedures performed each year. The United States, in particular, holds a leading position due to the prevalence of dental problems, extensive dental insurance coverage, and the presence of key market participants. Furthermore, the region benefits from widespread adoption of modern dental technologies and advantageous reimbursement regulations, which strengthens its global market leadership.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This rapid growth is being driven by rising disposable incomes, more access to dental services, and increased knowledge of oral hygiene in emerging nations such as China, India, and South Korea. Government actions to improve healthcare infrastructure and promote oral health, together with a growing middle-class population wanting superior dental treatment, are driving market growth. The region's rapid economic expansion and healthcare modernization make it an important growth engine for the sector.
Key players in the market
Some of the key players in Dental Sutures Market include Johnson & Johnson Services, Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Mani, Inc., HYGITECH, SMI (Surgical Specialties Corporation), DemeTECH Corporation, Osteogenics Biomedical, Lux Sutures, Sutumed Corp., Assut Europe SpA, Medtronic Plc, Zimmer Biomet Holdings Inc., Dentsply Sirona, Integra LifeSciences, W. L. Gore and Associates Inc., Katsan Medical Devices and Corza Medical.
In June 2024, MANI, Inc. announced the establishment of a new sales subsidiary in North America, named MANI MEDICAL AMERICA INC. (MMA). The subsidiary is set to begin operations in January 2025, with the goal of expanding sales through regional-oriented marketing and collaborating with Key Opinion Leader (KOL) doctors to develop the market.
In March 2024, Advanced Medical Solutions Group plc (AIM: AMS), a world-leading specialist in tissue healing technologies, is pleased to announce it has entered into an agreement for the proposed acquisition of Peters Surgical, a leading global provider of specialty surgical sutures, mechanical haemostasis and internal cyanoacrylate devices.